EMA fast tracks review of a medicine for metastatic pancreatic cancer

View source ↗

Summary

EMA has started a phased review to accelerate assessment of a medicine with potential to treat metastatic pancreatic cancer, addressing a high unmet medical nee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Phased review has started to accelerate assessment of medicine with potential to address high unmet medical need